Group 1: Medical Devices Industry - The brain-computer interface (BCI) market is at a critical turning point characterized by technological breakthroughs, clinical validation, and commercialization [1] - The first invasive brain-computer interface medical device has been approved for clinical use in China, marking a significant milestone in the global BCI market [2] - The product is designed for patients with quadriplegia due to cervical spinal cord injuries, significantly improving hand function and quality of life [2][3] - Clinical trials have shown 100% success in achieving primary clinical endpoints, with over 7000 days of safe implantation reported [3] - The Chinese government is actively promoting the BCI industry through policies and financial support, aiming to establish a robust industrial system by 2030 [4] Group 2: Economic Overview - The Chinese economy is showing strong signs of recovery, with significant improvements in production, consumption, and investment [8] - Industrial value-added output increased by 6.3% year-on-year, driven by high-end manufacturing and a broad recovery across various sectors [22] - Retail sales grew by 2.8% year-on-year, with service consumption and online sales performing particularly well [22] - Fixed asset investment saw a V-shaped recovery, with a cumulative year-on-year growth of 1.8%, although real estate investment remains in negative territory [22] Group 3: Aviation Industry - The 2026 Spring Festival travel period saw a record high in air passenger volume, with a year-on-year increase of 5.3% [34] - Domestic airfares are expected to rise by approximately 3-4% year-on-year during the Spring Festival, driven by high passenger loads [35] - The upcoming summer flight schedule will see a reduction in domestic flight plans, reflecting ongoing regulatory measures to control capacity growth [36] - The aviation industry is anticipated to enter a "super cycle" of profitability, supported by market demand and pricing dynamics [37]

Core Viewpoint - The article discusses the upcoming IPOs in the A-share market, highlighting the potential high subscription rate for Shenglong Co., a leading molybdenum company in China, due to its significant issuance volume and market position [1][11]. Group 1: Company Profiles - Vision Technology is a global leader in micro-display solutions, focusing on silicon-based OLED micro-displays, and has developed several core technologies that surpass competitors like Sony [2]. - Hongming Electronics specializes in new electronic components, particularly capacitors and resistors, and has achieved multiple domestic firsts in production lines, becoming a key supplier for major brands like Apple [4]. - Yuelong Technology produces flexible pipelines for fluid transport, with applications in extreme conditions, and serves major clients in various industries, including oil and gas [6]. - Taijin New Energy focuses on high-end green electrolysis equipment and titanium electrodes, with products used in various high-tech fields, including 5G and new energy vehicles [8]. - Huigu New Materials is dedicated to functional polymer materials, aiming to become a global leader in this sector, with a focus on resin and coating materials [10]. - Shenglong Co. is a major player in the molybdenum industry, with a strong production capacity and strategic location in China's largest molybdenum mining area, contributing significantly to the national output [11]. Group 2: Financial Projections - Vision Technology expects revenues of 215 million, 280 million, and 513 million yuan from 2023 to 2025, with net losses projected at 304 million, 247 million, and 212 million yuan [3]. - Hongming Electronics anticipates revenues of 2.727 billion, 2.494 billion, and 2.617 billion yuan, with net profits of 412 million, 268 million, and 319 million yuan over the same period [4]. - Yuelong Technology projects revenues of 219 million, 268 million, and 289 million yuan, with net profits of 61 million, 83 million, and 90 million yuan [6]. - Taijin New Energy forecasts revenues of 1.669 billion, 2.194 billion, and 2.395 billion yuan, with net profits of 155 million, 195 million, and 204 million yuan [8]. - Huigu New Materials expects revenues of 717 million, 817 million, and 985 million yuan, with net profits of 109 million, 146 million, and 207 million yuan [10]. - Shenglong Co. anticipates revenues of 1.957 billion, 2.864 billion, and 3.503 billion yuan, with net profits of 619 million, 757 million, and 884 million yuan from 2023 to 2025 [12].

IPO Review and Registration Progress - Three companies passed the IPO review last week, including Hongban Technology, Taijin New Energy, and Jiangtian Technology, with Hongban Technology focusing on high-end printed circuit boards for major smartphone brands [2][3] - Taijin New Energy specializes in high-end green electrolysis equipment and has faced scrutiny regarding its future performance stability and revenue recognition policies [3] - Jiangtian Technology, engaged in label printing products, reported a revenue increase of 10.85% year-on-year for the first three quarters of 2025 [3] Upcoming IPOs - Five companies are set to undergo IPO reviews this week, including Qilong Ocean and Shaanxi Tourism, with Shaanxi Tourism aiming to raise 1.55 billion yuan for various tourism-related projects [4][7] - Qilong Ocean's revenue heavily relies on its partnership with CNOOC, with sales to CNOOC accounting for over 75% of its revenue in recent years [4] - Haisheng Medical, focusing on anesthesia and monitoring medical devices, reported a revenue decline due to decreased sales in various regions [6] New Stock Listings - Danana Biological officially listed on the North Exchange, with a first-day increase of nearly 500%, closing at 102.10 yuan per share [11] - Four new stocks were listed last week, including Heyuan Biological and Taikai Ying, with significant first-day gains [12] - This week, three new stocks are scheduled for subscription, including Beikang Detection, which aims to raise 1.79 billion yuan for advanced testing equipment development [13][14]